AT369650B - Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivaten - Google Patents
Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivatenInfo
- Publication number
- AT369650B AT369650B AT0194780A AT194780A AT369650B AT 369650 B AT369650 B AT 369650B AT 0194780 A AT0194780 A AT 0194780A AT 194780 A AT194780 A AT 194780A AT 369650 B AT369650 B AT 369650B
- Authority
- AT
- Austria
- Prior art keywords
- indole
- content
- acid derivatives
- parenteral administration
- producing stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792914789 DE2914789A1 (de) | 1979-04-11 | 1979-04-11 | Injizierbare arzneimittel mit entzuendungshemmender wirkung |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA194780A ATA194780A (de) | 1982-06-15 |
AT369650B true AT369650B (de) | 1983-01-25 |
Family
ID=6068138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT0194780A AT369650B (de) | 1979-04-11 | 1980-04-10 | Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivaten |
Country Status (14)
Country | Link |
---|---|
US (1) | US4309420A (de) |
JP (1) | JPS55147217A (de) |
AT (1) | AT369650B (de) |
AU (1) | AU539043B2 (de) |
BE (1) | BE882732A (de) |
CA (1) | CA1136048A (de) |
CH (1) | CH642547A5 (de) |
DE (1) | DE2914789A1 (de) |
FR (1) | FR2453646A1 (de) |
GB (1) | GB2047535B (de) |
IT (1) | IT1148791B (de) |
NL (1) | NL8002096A (de) |
SE (1) | SE451428B (de) |
ZA (1) | ZA802158B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3042365C2 (de) * | 1980-11-10 | 1987-01-29 | Extrakta Strauss GmbH, 2000 Hamburg | Flüssige, lecithinhaltige einphasige Mehrstoffsysteme und Verfahren zu ihrer Herstellung |
JPS59152348A (ja) * | 1983-02-19 | 1984-08-31 | Kaken Pharmaceut Co Ltd | ビフエニリルプロピオン酸エステル誘導体およびその製造法 |
US5196567A (en) * | 1983-02-19 | 1993-03-23 | Kaken Pharmaceutical Co., Ltd. | Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
CA1237670A (en) * | 1983-05-26 | 1988-06-07 | Andrew S. Janoff | Drug preparations of reduced toxicity |
JPS601122A (ja) * | 1983-06-20 | 1985-01-07 | Green Cross Corp:The | ビフエニリルプロピオン酸誘導体脂肪乳剤 |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
IT1269569B (it) * | 1994-04-22 | 1997-04-08 | Ugo Citernesi | Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento |
US5763422A (en) * | 1995-01-27 | 1998-06-09 | Board Of Regents, The University Of Texas System | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
EP1214940B1 (de) * | 1995-01-27 | 2009-03-11 | Board of Regents, The University of Texas System | Methoden zur Erhöhung der Wirksamkeit von nicht-steroidalen antientzündlichen Arzneien und dazu verwendbare Zusammensetzungen enthaltend zwitterionische Phospholipide |
US5955451A (en) * | 1995-05-12 | 1999-09-21 | The University Of Texas System Board Of Regents | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
US20040077604A1 (en) | 2001-12-19 | 2004-04-22 | Lenard Lichtenberger | Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity |
MX340951B (es) | 2011-09-29 | 2016-07-29 | Plx Pharma Inc | Portadores dependientes del ph para la liberacion dirigida de productos farmaceuticos a lo largo del tracto gastrointestinal, composiciones de los mismos, y fabricación y uso de las mismas. |
MX2022011743A (es) | 2020-03-26 | 2022-12-08 | Plx Opco Inc | Portadores farmaceuticos con capacidad de reconstitucion dependiente del ph y metodos para elaborar y usar los mismos. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA725596A (en) * | 1960-08-26 | 1966-01-11 | J. Wretlind Arvid | Method of preparing intravenously injectable fat emulsions free from side reactions or complications |
GB1214515A (en) * | 1967-04-11 | 1970-12-02 | Sumitomi Chemical Company Ltd | Indole derivatives and salts thereof |
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
US4093733A (en) * | 1976-09-09 | 1978-06-06 | Merck & Co., Inc. | Parenteral suspensions |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
DE2856333C2 (de) * | 1978-12-27 | 1983-09-22 | A. Nattermann & Cie GmbH, 5000 Köln | Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung |
-
1979
- 1979-04-11 DE DE19792914789 patent/DE2914789A1/de active Granted
-
1980
- 1980-04-08 GB GB8011633A patent/GB2047535B/en not_active Expired
- 1980-04-08 CA CA000349306A patent/CA1136048A/en not_active Expired
- 1980-04-09 FR FR8007938A patent/FR2453646A1/fr active Granted
- 1980-04-10 BE BE0/200183A patent/BE882732A/fr not_active IP Right Cessation
- 1980-04-10 US US06/139,117 patent/US4309420A/en not_active Expired - Lifetime
- 1980-04-10 CH CH274580A patent/CH642547A5/de not_active IP Right Cessation
- 1980-04-10 NL NL8002096A patent/NL8002096A/nl not_active Application Discontinuation
- 1980-04-10 ZA ZA00802158A patent/ZA802158B/xx unknown
- 1980-04-10 AU AU57330/80A patent/AU539043B2/en not_active Ceased
- 1980-04-10 SE SE8002715A patent/SE451428B/sv not_active IP Right Cessation
- 1980-04-10 IT IT21300/80A patent/IT1148791B/it active
- 1980-04-10 AT AT0194780A patent/AT369650B/de not_active IP Right Cessation
- 1980-04-10 JP JP4632280A patent/JPS55147217A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2453646B1 (de) | 1985-01-25 |
FR2453646A1 (fr) | 1980-11-07 |
CA1136048A (en) | 1982-11-23 |
GB2047535A (en) | 1980-12-03 |
US4309420A (en) | 1982-01-05 |
JPH0210805B2 (de) | 1990-03-09 |
AU539043B2 (en) | 1984-09-06 |
ZA802158B (en) | 1981-05-27 |
GB2047535B (en) | 1983-10-26 |
IT1148791B (it) | 1986-12-03 |
DE2914789A1 (de) | 1980-10-16 |
ATA194780A (de) | 1982-06-15 |
SE451428B (sv) | 1987-10-12 |
SE8002715L (sv) | 1980-10-12 |
JPS55147217A (en) | 1980-11-17 |
CH642547A5 (de) | 1984-04-30 |
BE882732A (fr) | 1980-07-31 |
AU5733080A (en) | 1980-10-16 |
IT8021300A0 (it) | 1980-04-10 |
NL8002096A (nl) | 1980-10-14 |
DE2914789C2 (de) | 1991-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA195880A (de) | Verfahren zur herstellung von stabilen injektions-praeparaten zur parenteralen verabreichung enthaltend aryl- bzw. heteroarylessigsaeure- bzw. aryl- bzw. heteroarylpropionsaeurederivate | |
AT369650B (de) | Verfahren zur herstellung von stabilen injektionspraeparaten zur parenteralen verabreichung mit einem gehalt an indol- oder indanessigsaeurederivaten | |
AT387517B (de) | Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten | |
AT361121B (de) | Verfahren zur herstellung von neuen 7beta-aryl- malonamido-7alpha-methoxy-3-thiadiazolylthio-1- -oxadethiacephalosporinen und deren estern und salzen mit basen | |
AT368168B (de) | Verfahren zur herstellung von neuen thioetiansaeurederivaten | |
ATA115186A (de) | Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung | |
AT361462B (de) | Verfahren zur herstellung von neuen halogen- substituierten 1-niederalkyl-5-aroyl-pyrrol-2- -essigsaeure-derivaten | |
ATA495580A (de) | Verfahren zur herstellung von infusionsloesungen zur pareutalen ernaehrung | |
AT361280B (de) | Verfahren zur herstellung eines stabilen nahrungs- und futtermittels | |
AT358572B (de) | Verfahren zur herstellung von 5-aroyl-1- niederalkyl-pyrrol-2-essigsaeure-derivaten | |
AT388670B (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung mit einem gehalt an calciumantagonisten | |
AT359197B (de) | Verfahren zur herstellung von pharmazeutischen praeparaten | |
AT360149B (de) | Verfahren zur herstellung einer injektions- zubereitung mit einem gehalt an chloramphenicol | |
DD128196A5 (de) | Verfahren zur herstellung von clavulansaeure-thioaethern | |
AT363591B (de) | Verfahren zur herstellung von lebendimpfstoffen mit einem gehalt an stabilen, hochimmunogenen bakterienmutanten | |
AT379382B (de) | Verfahren zur herstellung von neuen n-substituierten aziridin-2-carbonsaeurederivaten | |
ATA118980A (de) | Verfahren zur herstellung von 6-ss-jod-penicillan- saeure-derivaten | |
AT370418B (de) | Verfahren zur herstellung von derivaten der 7-aminothiazolylacetamidocephalosporansaeure | |
AT363181B (de) | Verfahren zur herstellung von neuen clavulansaeurederivaten | |
ATA920276A (de) | Verfahren zur herstellung von neuen thiadiazolyl-derivaten der 7-acylamido-3-cephem-4-carbonsaeure | |
ATA557980A (de) | Verfahren zur herstellung von apovincaminsaeureester-derivaten | |
ATA39679A (de) | Verfahren zur herstellung von ergopeptidalkaloid -derivaten | |
AT356083B (de) | Verfahren zur herstellung von neuen estern von phenylaethylaminderivaten und von deren saeure- additionssalzen | |
AT364847B (de) | Verfahren zur herstellung von neuen clavulansaeurederivaten | |
AT381232B (de) | Verfahren zur herstellung stabiler fluessiger loesungen von ergolinderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee | ||
UEP | Publication of translation of european patent specification |